FACTORS ASSOCIATED TO QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS

Nelbe Nesi Santana, Célia Regina Moutinho de Miranda Chaves, Christine Pereira Gonçalves, Saint Clair Dos Santos Gomes Junior, Nelbe Nesi Santana, Célia Regina Moutinho de Miranda Chaves, Christine Pereira Gonçalves, Saint Clair Dos Santos Gomes Junior

Abstract

Objective: To verify the association between quality of life, functional capacity and clinical and nutritional status in children and adolescents with cystic fibrosis (CF).

Methods: Cross-sectional study, including patients from eight to 18 years old with CF. Quality of life, functional capacity, nutritional status and clinical status were evaluated with the Cystic Fibrosis Questionnaire; the 6-minute walk test (6MWT) and manual gripping force (MGF); the height percentiles for age and body mass index for age and respiratory function test, respectively. Pearson and Spearman correlation tests and logistic regression were used to analyze the data.

Results: A total of 45 patients, 13.4±0.5 years old, 60% female, 60% colonized by Pseudomonas aeruginosa and 57.8% with at least one F508del mutation participated in the study. When assessing the perception of quality of life, the weight domain reached the lowest values, and the digestive domain, the highest. In the pulmonary function test, the forced expiratory volume of the first second was 77.3±3.3% and the 6MWT and MGF presented values within the normal range. There was an association between quality of life and functional capacity, nutritional status and clinical status of CF patients.

Conclusions: The study participants had good clinical conditions and satisfactory values of functional capacity and quality of life. The findings reinforce that the assessment of quality of life may be important for clinical practice in the management of treatment.

Conflict of interest statement

The authors declare there is no conflict of interests.

References

    1. Máiz L, Baranda F, Coll R, Prados C, Vendrell M, Escribano A, et al. Normativa del diagnóstico y el tratamiento de la afección respiratoria en la fibrosis quística. Arch Bronconeumol. 2001;37:316–324. doi: 10.1016/S0300-2896(01)75101-0.
    1. Pinto IC, Silva CP, Britto MC. Nutritional, clinical and socioeconomic profile of patients with cystic fibrosis treated at a referral center in northeastern Brazil. J Bras Pneumol. 2009;35:137–143. doi: 10.1590/S1806-37132009000200006.
    1. Bush A, Alton EWFW, Davies JC, Griesenbach U, Jaffe A. Cystic fibrosis in the 21st Century. Respir Res. 2006;34:1–10.
    1. Corriveau S, Sykes J, Stephenson AL. Cystic fibrosis survival: the changing epidemiology. Curr Opin Pulm Med. 2018;24:574–578. doi: 10.1097/MCP.0000000000000520.
    1. Grupo Brasileiro de Estudos de Fibrose Cística . Registro Brasileiro de Fibrose Cística 2016. São Paulo: Grupo Brasileiro de Estudos de Fibrose Cística; 2017. [2019 mar. 06]. [homepage on the Internet] Available from: .
    1. Elborn S. The management of young adults with cystic fibrosis: ‘genes, jeans and genies’. Disabil Rehabil. 1998;20:217–225. doi: 10.3109/09638289809166732.
    1. Pereira FM, Ribeiro MA, Ribeiro AF, Toro AA, Hessel G, Ribeiro JD. Functional performance on the six-minutewalk test in patients with cystic fibrosis. J Bras Pneumol. 2011;37:735–744. doi: 10.1590/s1806-37132011000600006.
    1. Ziegler B, Rovedder PM, Oliveira CL, Schuh SJ, Silva FA, Dalcin PT. Predictors of oxygen desaturation during the six-minute walk test in patients with cystic fibrosis. J Bras Pneumol. 2009;35:957–965. doi: 10.1590/S1806-37132009001000003.
    1. Sampaio RF, Mancini MC, Gonçalves GG, Bittencourt NF, Miranda AD, Fonseca ST. Application of the international classification of functioning, disability and health (ICF) in physiotherapists’ clinical practice. Rev Bras Fisioter. 2005;9:129–136.
    1. Steinkamp G, Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax. 2002;57:596–601. doi: 10.1136/thorax.57.7.596.
    1. Adler FR, Aurora P, Barker DH, Barr ML, Blackwell LS, Bosma OH, et al. Lung transplantation for cystic fibrosis. Proc Am Thorac Soc. 2009;6:619–633. doi: 10.1513/pats.2009008-088TL.
    1. [No authors listed] The World Health Organization Quality of Life Assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41:403–409. doi: 10.1016/0277-9536(95)00112-k.
    1. Zanni RL, Sembrano EU, Du DT, Marra B, Bantang R. The impact of re-education of airway clearance techniques (REACT) on adherence and pulmonary function in patients with cystic fibrosis. BMJ Qual Saf. 2014;23(1):i50–i55. doi: 10.1136/bmjqs-2013-002352.
    1. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4–14. doi: 10.1016/j.jpeds.2008.05.005.
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS Statement: guidelines for the six minute walk test. Am J Respir Crit Care Med. 2002;166:111–117. doi: 10.1164/ajrccm.166.1.at1102.
    1. Priesnitz CV, Rodrigues GH, Stumpf CS, Viapiana G, Cabral CP, Stein RT, et al. Reference values for the 6-min walk test in healthy children aged 6-12 years. Pediatr Pulmonol. 2009;44:1174–1179. doi: 10.1002/ppul.21062.
    1. American Society of Hand Therapists . Clinical assessment recommendations. Chicago: ASHT; 1992.
    1. Sartorio A, Lafortuna CL, Pogliaghi S, Trecate L. The impact of gender, body dimension and body composition on hand-grip strength in healthy children. J Endocrinol Invest. 2002;25:431–435. doi: 10.1007/BF03344033.
    1. Quittner AL, Buu A, Messer MA, Modi AC, Watrous M. Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest. 2005;128:2347–2354. doi: 10.1378/chest.128.4.2347.
    1. Rozov T, Cunha MT, Nascimento O, Quittner AL, Jardim JR. Linguistic validation of cystic fibrosis quality of life questionnaires. J Pediatr. 2006;82:151–156. doi: 10.2223/JPED.1463.
    1. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968. doi: 10.1183/09031936.05.00035205.
    1. Mukaka MM. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012;24:69–71.
    1. van de Weert-van Leeuwen PB, Slieker MG, Hulzebos HJ, Kruitwagen CL, van der Ent CK, Arets HG. Chronic infection and inflammation affect exercise capacity in cystic fibrosis. Eur Respir J. 2012;39:893–898. doi: 10.1183/09031936.00086211.
    1. Salvatore D, Buzzetti R, Mastella G. Update of literature from cystic fibrosis registries 2012-2015. Part 6: Epidemiology, nutrition and complications. Pediatr Pulmonol. 2017;52:390–398. doi: 10.1002/ppul.23611.
    1. Arrington-Sanders R, Yi MS, Tsevat J, Wilmon RW, Mrus JM, Britto MT. Gender differences in health-related quality of life of adolescents with cystic fibrosis. Health Qual Life Outcomes. 2006;4:5–5. doi: 10.1186/1477-7525-4-5.
    1. Dill EJ, Dawson R, Sellers DE, Robinson WM, Sawicki GS. Longitudinal trends in health-related quality of life in adults with cystic fibrosis. Chest. 2013;144:981–989. doi: 10.1378/chest.12-1404.
    1. Burtin C, Remoortel HV, Vrijsen B, Langer D, Colpaert K, Gosselink R, et al. Impact of exacerbations of cystic fibrosis on muscle strength. Respir Res. 2013;14:46–46. doi: 10.1186/1465-9921-14-46.
    1. Havermans T, Colpaert K, Vanharen L, Dupont LJ. Health related quality of life in cystic fibrosis: to work or not to work? J Cyst Fibros. 2009;8:218–223. doi: 10.1016/j.jcf.2009.03.002.
    1. Borawska-Kowalczyk U, Sands D. Determinants of health-related quality of life in polish patients with CF - adolescents’ and parents’ perspectives. Dev Period Med. 2015;19:127–136.
    1. Donadio MV, Heinzmann-Filho JP, Vendrusculo FM, Frasson PX, Marostica PJ. Six-minute walk test results predict risk of hospitalization for youths with cystic fibrosis: a 5-year follow-up study. J Pediatr. 2017;182:204–209. doi: 10.1016/j.jpeds.2016.11.071.
    1. Quittner AL, Sawicki GS, McMullen A, Rasouliyan L, Pasta DJ, Yegin A, et al. Psychometric evaluation of the cystic fibrosis questionnaire-revised in a national, US sample. Qual Life Res. 2012;21:1267–1278. doi: 10.1007/s11136-011-0036-z.
    1. Royce FH, Carl JC. Health-related quality of life in cystic fibrosis. Curr Opin Pediatr. 2011;23:535–540. doi: 10.1097/MOP.0b013e32834a7829.
    1. Habib AR, Manji J, Wilcox PG, Javer AR, Buxton JA, Quon BS. A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis. Ann Am Thorac Soc. 2015;12:420–428. doi: 10.1513/AnnalsATS.201408-393OC.
    1. Goss CH, Quittner AL. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc. 2007;4:378–386. doi: 10.1513/pats.200703-039BR.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner